Brighthouse Financial, Inc. (BHF) Stock Price & Analysis
Brighthouse Financial, Inc. (BHF) closed at USD 46.35 on Thursday, October 22, 2026, down 1.30% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 46.96; the Oct 22, 2026 session ranged USD 45.62–46.96 on volume of 794,828 shares. Market capitalization is $2.67B, with a 52-week range of USD 45.62–66.8 (NMS). Source: Nexqual, retrieved October 23, 2026 at 09:22 UTC.
Also available as compact Markdown for AI agents: nexqual.com/BHF.md
Key facts (BHF)
- Last four reported quarters (through Jun 30, 2026): revenue $6.65B, net income $831M (12.5% margin) (SEC filings).
- Valuation: P/E 3.2x (avg 8.1x at the last 2 fiscal year-ends).
- 1 of 80 tracked superinvestors hold BHF (13F, Q2 2026): 0 new, 0 added, 0 reduced, 1 unchanged.
- Analysts: Hold (mean 3.00 on a 1–5 scale) (7 analysts), mean target USD 61.67 (range 55–70).
- Total return with dividends: 1Y -1.4% vs S&P 500 +14.9%; 5Y -11.6% vs S&P 500 +80.3%.
- Next earnings: 2026-11-05, EPS estimate USD 4.94, revenue estimate $2.21B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (BHF)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $4.98B | $6.87B | $4.12B | $4.72B | $6.77B | $6.65B |
| Net income | $1.64B | $3.88B | -$1.11B | $388M | $433M | $831M |
| EPS (diluted) | $18.39 | $51.30 | -$18.39 | $4.64 | $5.71 | — |
| Net margin | 33.0% | 56.4% | -27.0% | 8.2% | 6.4% | 12.5% |
| Revenue growth | -41.5% | +38.1% | -40.1% | +14.7% | +43.2% | — |
| Cash + short-term investments | $6.32B | $5.20B | $5.02B | $6.91B | $6.58B | — |
| Total debt | $3.16B | $3.16B | $3.16B | $3.15B | $3.15B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (BHF)
P/E 3.2x · P/S 0.4x · P/B 0.4x · Earnings yield 31.17% · Buyback yield (TTM) 0.00%
P/E at fiscal year-ends: Dec 2025 8.7x, Dec 2024 7.6x.
Superinvestors (SEC 13F-HR, Q2 2026) (BHF)
1 of 80 tracked investors hold BHF. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| David Einhorn | Greenlight Capital | 4.60% | $180M | Unchanged |
Analysts (BHF)
Consensus Hold (mean 3.00 on a 1–5 scale), 7 analysts; mean target USD 61.67 (low 55, high 70).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-15 | JP Morgan | Upgrade | Underweight → Neutral | $63 → $55 |
| 2026-10-15 | Keefe, Bruyette & Woods | Target lowered | Market Perform | $57 → $55 |
| 2026-10-09 | Keefe, Bruyette & Woods | Target lowered | Market Perform | $67 → $57 |
Total return (dividends reinvested) (BHF)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | -1.4% | -11.6% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -1.4% | -2.4% |
| Volatility (annualized) | 37.2% | 38.1% |
| Max drawdown | -30.4% (Jul 2026→Oct 2026) | -32.6% (Feb 2023→May 2023) |
BHF revenue by business segment (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Annuities | $852.0M | 52.5% | +321.8% |
| Run-off | $358.0M | 22.1% | +71.3% |
| Life | $265.0M | 16.3% | -1.5% |
| Corporate Segment and Other Operating | $147.0M | 9.1% | -23.0% |
| Total revenue | $1.62B | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
BHF suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Partner | METLIFE INC (MET) | “Under the tax separation agreement with MetLife, Inc. (the "Tax Separation Agreement"), MetLife is generally obligated to indemnify us against such taxes if the failure to qualify for tax-free treatment results from, among other things, any action or inaction that is within MetLife's control.” |
Quoted from the company's 10-K filed Feb 24, 2026.
BHF company outlook (results filed Aug 5, 2026)
- “The merger is expected to close in 2026.”
Quoted word-for-word from the SEC 8-K results press release.
BHF analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $4.94 | $5.22 | -5.5% | $2.21B | 4 |
| Next quarter (ends Dec 2026) | $4.77 | $5.15 | -7.2% | $2.20B | 4 |
| Current fiscal year (ends Dec 2026) | $19.06 | $19.60 | -2.8% | $8.64B | 5 |
| Next fiscal year (ends Dec 2027) | $20.08 | $19.77 | +1.5% | $8.80B | 4 |
Key Statistics (as of October 23, 2026 at 09:22 UTC)
| Price | USD 46.35 |
|---|---|
| Change | ▼ 1.30% (down) |
| Previous Close | USD 46.96 |
| Open | USD 46.78 |
| Day Range | USD 45.62 – 46.96 |
| 52-Week Range | USD 45.62 – 66.8 |
| Volume | 794,828 shares |
| Market Cap | $2.67B |
| Exchange | NMS |
Technical Analysis (BHF)
Nexqual's technical model rates BHF "SELL" based on 2 bullish and 5 bearish signals across 127 daily candles, as of October 23, 2026 at 09:22 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 26.18 (oversold) |
| vs SMA50 | Below (USD 51.18) |
| MACD | -1.37 (negative) |
Analyst Ratings (BHF)
Wall Street analysts rate BHF "Hold" based on 7 analysts, with a mean price target of USD 61.67 (range USD 55–70), per Nexqual as of October 23, 2026 at 09:22 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 7 |
| Mean Target | USD 61.67 |
| High Target | USD 70 |
| Low Target | USD 55 |
| Buy / Hold / Sell | 0 / 7 / 0 |
Earnings (BHF)
| Next Earnings Date | 2026-11-05 |
|---|---|
| EPS Estimate | USD 4.94 |
| Revenue Estimate | $2.21B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 4.45 vs est 4.77 ▼ miss |
| 2026-03-31 | USD 4.35 vs est 4.47 ▼ miss |
| 2025-12-31 | USD 3.7 vs est 5.19 ▼ miss |
| 2025-09-30 | USD 4.54 vs est 5.03 ▼ miss |
Source: Nexqual, October 23, 2026 at 09:22 UTC.
Financials & Fundamentals (BHF)
| Total Revenue | $6.84B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +86.70% |
| Gross Margin | +35.44% |
| Operating Margin | +77.78% |
| Profit Margin | +12.15% |
| ROE | +13.54% |
| Debt / Equity | 1.78 |
| Current Ratio | 0.77 |
| Total Cash | $8.87B |
| Total Debt | $11.80B |
Source: Nexqual, October 23, 2026 at 09:22 UTC.
Financial Health Score (BHF)
Nexqual rates Brighthouse Financial, Inc.'s overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 09:22 UTC.
| Growth | Weak — Revenue -1% YoY (annual), declining |
|---|---|
| Profitability | Solid — Gross margin 35% (last 12 months) |
| Balance Sheet | Critical — $6.14B cash and investments vs $3.15B debt (Mar 2026, SEC), net cash |
| Cash Flow | Solid — Operating cash flow $259M (FY ended Dec 2025, 10-K) |
| Efficiency | Mixed — ROE 14%, ROA 0.3% |
Ownership (BHF)
| Insider Ownership | +1.42% |
|---|---|
| Institutional Ownership | +92.89% |
| Shares Outstanding | 57.51M |
| Float | 56.66M |
| Short % of Float | +14.31% |
Source: Nexqual, October 23, 2026 at 09:22 UTC.
Leadership (BHF)
Brighthouse Financial, Inc. is led by Eric Thomas Steigerwalt, President, CEO & Director, per Nexqual as of October 23, 2026 at 09:22 UTC.
| President, CEO & Director | Eric Thomas Steigerwalt |
|---|---|
| Executive VP & CFO | Edward Allen Spehar |
| Executive VP & COO | Myles Joseph Lambert |
| Executive VP & CTO | Jeff Hughes |
Major Backers & Investors (BHF)
Notable institutional backers of Brighthouse Financial, Inc. include UBS Group AG, DME Capital Management, LP, American Century Companies Inc, according to Nexqual as of October 23, 2026 at 09:22 UTC.
Active Investors
| Investor | Stake |
|---|---|
| UBS Group AG | 7.3% |
| DME Capital Management, LP | 4.94% |
| American Century Companies Inc | 4.61% |
| Morgan Stanley | 3.27% |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Small Cap Value Portfolio | 2.18% |
| Millennium Management | 2.12% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 9.38% |
| Vanguard Group | 8.85% |
| Dimensional Fund Advisors | 6.32% |
| State Street | 3.62% |
Source: Nexqual, October 23, 2026 at 09:22 UTC.
From Brighthouse Financial, Inc.'s Latest SEC 10-K Filing (filed 2026-02-24)
Key Strengths & Strategy (as disclosed to the SEC)
- We are one of the largest providers of annuity and life insurance products in the U.S. with over 2.0 million annuity contracts and insurance policies in force at December 31, 2025.
- We believe we have the underwriting approach, product design capabilities and distribution relationships that allows us to offer new products that meet our risk-adjusted return objectives and that such capabilities will enhance our ability to maintain market presence and relevance over the long-term.
- Surrender charges allow us to recoup amounts we expended to initially market and sell such annuities.
Partnerships
- Investment management fees are also paid on the non-proprietary funds managed by investment advisors unaffiliated with us, to the unaffiliated investment advisors.
- On a case-by-case basis, we may retain up to $20 million per life and reinsure 100% of the risk in excess of the amount we retain.
Legal & Regulatory Risks (Item 1A, quoted)
- Changes to the laws and regulations that govern the standards of conduct that apply to the sale of our products, as well as the firms that distribute our products, could adversely affect our operations and profitability.
- We cannot predict the impact that "best interest" or fiduciary standards may have on our business, financial condition or results of operations.
- Changes in tax laws or interpretations of such laws could have a material adverse effect on our profitability and financial condition and could result in our incurring materially higher statutory taxes.
- Current claims, litigation, unasserted claims probable of assertion, investigations and other proceedings against us, as well as any other disputes or other matters involving third parties, could have a material adverse effect on our business, financial condition and results of operations.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| FG | F&G Annuities & Life, Inc. | USD 21.45 | ▲ 5.3% |
| GNW | Genworth Financial Inc | USD 8.94 | ▲ 1.02% |
| CNO | CNO Financial Group, Inc. | USD 55.5 | ▲ 0.16% |
| LNC | Lincoln National Corporation | USD 41.11 | ▲ 1.78% |
| ABX | Abacus Global Management, Inc. | USD 8.51 | ▲ 0.12% |
| PRI | Primerica, Inc. | USD 285.72 | ▲ 0.38% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:22 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt